Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/27/18
End: 04/22/19
Due: 04/22/20
Phase: N/A
Priority: Normal
Start: 08/31/15
End: 11/30/15
Due: 11/30/16
Phase: N/A
Priority: Normal
Start: 06/30/15
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 03/31/12
End: 04/30/12
Due: 04/30/13
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris | NCT03522441 | Akorn, Inc. | user2@example.com | None | 2018-04-27 | 2019-04-22 | 2020-04-22 | - | - | 2025-07-14 |
| Bioequivalence Study for Benzyl Alcohol Lotion 5%. | NCT02624843 | Akorn, Inc. | user2@example.com | None | 2015-08-31 | 2015-11-30 | 2016-11-30 | - | - | 2025-07-14 |
| Bioequivalence Study With Clinical Endpoint for Diclofenac Sodium Topical Gel 1% | NCT02913521 | Akorn, Inc. | user2@example.com | None | 2015-06-30 | 2016-06-30 | 2017-06-30 | - | - | 2025-07-14 |
| An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis | NCT01561521 | Akorn, Inc. | user2@example.com | None | 2012-03-31 | 2012-04-30 | 2013-04-30 | - | - | 2025-07-14 |